Mark S Leventhal, a director of ProPhase Labs, recently acquired 35,752 shares of the company. The buys took place at $1.30 per share, on dates ranging from November 24 to November 25, 2015. Leventhal now owns 1,047,732 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.34, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.33, inclusive.
The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation
. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
Registration of securities [Section 12(g)] - Feb. 21, 2018
Securities registration termination [Section 12(g)] - Feb. 21, 2018
Prophase Labs, Inc. Announces NEW COMPENSATORY ARRANGEMENT WITH CHIEF EXECUTIVE OFFICER AND TERMINATION OF STOCKHOLDER RIGHTS PLAN - Feb. 21, 2018
BML Investment Partners, L.P. just provided an update on share ownership of ProPhase Labs - Jan. 30, 2018